| Trial ID: | L0081 |
| Source ID: | NCT03068065
|
| Associated Drug: |
Liraglutide
|
| Title: |
Antidiabetic Effects on Intrahepatic Fat
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease|Type2 Diabetes
|
| Interventions: |
Drug: Liraglutide|Drug: Metformin|Drug: Gliclazide
|
| Outcome Measures: |
Intrahepatic fat|Liver function|Lipid|Plasma glucose in standard meal tolerance test|Plasma insulin in standard meal tolerance test|Glucose control|HbA1c|Body composition|Weight|WC
|
| Sponsor/Collaborators: |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
|
| Gender: |
All
|
| Age: |
17 Years to 80 Years ?? (Child, Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
87
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
May 2014
|
| Completion Date: |
October 2015
|
| Results First Posted: |
--
|
| Last Update Posted: |
March 1, 2017
|
| Locations: |
at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University, Nanjing, Jiangsu, China
|
| URL: |
https://ClinicalTrials.gov/show/NCT03068065
|
